R Mas Selected Research

policosanol

2/2017	[Long-term effect of policosanol on the functional recovery of non-cardioembolic ischemic stroke patients: a one year study].
11/2013	Therapeutic Effects of Policosanol and Atorvastatin against Global Brain Ischaemia-Reperfusion Injury in Gerbils.
1/2005	Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia.
1/2002	Comparison of the efficacy, safety and tolerability of original policosanol versus other mixtures of higher aliphatic primary alcohols in patients with type II hypercholesterolemia.
1/2001	Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.
1/2001	Efficacy and tolerability of policosanol in hypercholesterolemic postmenopausal women.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R Mas Research Topics

Disease

3	Hyperplasia 11/2011 - 01/2005
2	Brain Ischemia (Cerebral Ischemia) 02/2017 - 11/2013
2	Body Weight (Weight, Body) 01/2005 - 01/2003
2	Osteoporosis 01/2005 - 01/2005
2	Hypercholesterolemia 01/2002 - 01/2001
1	Stroke (Strokes) 02/2017
1	Ischemic Stroke 02/2017
1	Granuloma 03/2015
1	Pleurisy (Pleuritis) 03/2015
1	Inflammation (Inflammations) 03/2015
1	Reperfusion Injury 11/2013
1	Ischemia 11/2013
1	Metabolic Bone Diseases (Osteopenia) 01/2005
1	Bone Resorption 01/2005
1	Coronary Disease (Coronary Heart Disease) 01/2005
1	Headache (Headaches) 01/2005
1	Heartburn (Pyrosis) 01/2005
1	Nausea 01/2005
1	Pancreatitis 01/2003
1	Acute Necrotizing Pancreatitis 01/2003
1	Infections 06/2002
1	Vomiting 01/2001
1	Exanthema (Rash) 01/2001
1	Type 2 Diabetes Mellitus (MODY) 01/2001
1	Dyslipidemias (Dyslipidemia) 01/2001
1	Pruritus (Itching) 01/2001
1	Hypersensitivity (Allergy) 01/2001

Drug/Important Bio-Agent (IBA)

6	policosanolIBA 02/2017 - 01/2001
3	Testosterone (Sustanon)FDA Link 11/2011 - 01/2005
3	CholesterolIBA 01/2005 - 01/2001
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2017 - 11/2013
2	Therapeutic UsesIBA 11/2013 - 01/2005
2	LipidsIBA 11/2011 - 01/2005
2	AlcoholsIBA 01/2002 - 01/2001
1	D 002IBA 03/2015
1	Leukotriene B4IBA 03/2015
1	CarrageenanIBA 03/2015
1	Atorvastatin (Lipitor)FDA Link 11/2013
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 11/2011
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2011
1	Biomarkers (Surrogate Marker)IBA 01/2005
1	Prednisolone (Predate)FDA LinkGeneric 01/2005
1	AcidsIBA 01/2005
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2005
1	Alkaline PhosphataseIBA 01/2005
1	deoxypyridinolineIBA 01/2005
1	Bone Density Conservation AgentsIBA 01/2005
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2005
1	CreatinineIBA 01/2005
1	saw palmetto extractIBA 01/2005
1	Fish OilsIBA 01/2005
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2005
1	Mevalonic Acid (Mevalonate)IBA 01/2005
1	Amylases FDA Link 01/2003
1	AntioxidantsIBA 01/2003
1	EnzymesIBA 01/2003
1	Oxygen (Dioxygen)IBA 01/2003
1	salicylhydroxamic acid (SHAM)IBA 01/2003
1	Hepatitis A AntibodiesIBA 06/2002
1	SugarsIBA 01/2001
1	N 30IBA 01/2001
1	i-cholesterolIBA 01/2001

Therapy/Procedure

3	Therapeutics 02/2017 - 01/2003
2	Ovariectomy (Oophorectomy) 01/2005 - 01/2005
1	Canes (Cane) 01/2001